Cargando…
43. A Pharmacoepidemiologic Evaluation of Echinocandin Use
BACKGROUND: Invasive candidiasis (IC) is a common healthcare-associated infection. Rates of IC caused by drug-resistant Candida spp., designated by the CDC as a serious threat, are increasing, and Candida auris alone was recently added as an urgent threat. Echinocandins are guideline-preferred for t...
Autores principales: | Jo, Jinhee, Hendrickson, Joshua, Gonzales-Luna, Anne J, Beyda, Nicholas D, Garey, Kevin W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776070/ http://dx.doi.org/10.1093/ofid/ofaa439.088 |
Ejemplares similares
-
157. A Multicenter, Mixed-Method Evaluation of Delayed Hospital Discharge in Patients with Invasive Candidiasis Receiving Echinocandins
por: Jo, Jinhee, et al.
Publicado: (2021) -
195. Antimicrobial Stewardship Incorporating New Antimicrobials for Use against Multi-Drug Resistant Pseudomonas aeruginosa in Cystic Fibrosis
por: Jo, Jinhee, et al.
Publicado: (2020) -
381. Morphologic Changes Associated With Echinocandin Tolerance Enhance Immunoevasion of Candida glabrata
por: Hu, Chenlin, et al.
Publicado: (2018) -
18. Global Surveillance of Clostridioides difficile Demonstrates High Prevalence in Non-Healthcare Settings
por: Jo, Jinhee, et al.
Publicado: (2021) -
Development of the invasive candidiasis discharge [I Can discharge] model: a mixed methods analysis
por: Jo, Jinhee, et al.
Publicado: (2022)